niacinamide has been researched along with Neoplasms, Nerve Sheath in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant peripheral nerve sheath tumors (MPNSTs) have high malignant potential and poor prognosis because of aggressive progression and metastasis." | 1.43 | Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells. ( Goto, K; Iino, M; Kikuchi, N; Tanaka, T, 2016) |
| "Malignant schwannomas or malignant peripheral nerve sheath tumors (MPNST) represent approximately 10% of all soft tissue sarcomas." | 1.35 | Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review. ( Fenning, R; Gudena, V; Kizziah, M; Montero, AJ; Post, G; Verma, N, 2008) |
| "Malignant peripheral nerve sheath tumors (MPNST) are soft-tissue tumors with a very poor prognosis and largely resistant to chemotherapy." | 1.35 | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. ( Ambrosini, G; Cheema, HS; Sambol, EB; Schwartz, GK; Seelman, S; Singer, S; Teed, A, 2008) |
| "Malignant peripheral nerve sheath tumors are rare spindle-cell sarcomas derived from Schwann cells or pluripotent cells of the neural crest." | 1.33 | Spinal cord metastasis of a non-neurofibromatosis type-1 malignant peripheral nerve sheath tumor: an unusual manifestation of a rare tumor. ( Baek, WS; Pytel, P; Rubeiz, H; Undevia, SD, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 1 |
| Kikuchi, N | 1 |
| Goto, K | 1 |
| Iino, M | 1 |
| Baek, WS | 1 |
| Pytel, P | 1 |
| Undevia, SD | 1 |
| Rubeiz, H | 1 |
| Gudena, V | 1 |
| Verma, N | 1 |
| Post, G | 1 |
| Kizziah, M | 1 |
| Fenning, R | 1 |
| Montero, AJ | 1 |
| Ambrosini, G | 1 |
| Cheema, HS | 1 |
| Seelman, S | 1 |
| Teed, A | 1 |
| Sambol, EB | 1 |
| Singer, S | 1 |
| Schwartz, GK | 1 |
4 other studies available for niacinamide and Neoplasms, Nerve Sheath
| Article | Year |
|---|---|
Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Cell Line, Tumor; Doxorubi | 2016 |
Spinal cord metastasis of a non-neurofibromatosis type-1 malignant peripheral nerve sheath tumor: an unusual manifestation of a rare tumor.
Topics: Adult; Benzenesulfonates; Chemotherapy, Adjuvant; Fatal Outcome; Female; Humans; Lung Neoplasms; Mag | 2005 |
Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review.
Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Brain Neoplasms; Female; Humans; Lung Neoplasms; Ma | 2008 |
Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Differentiation; Cell P | 2008 |